Literature DB >> 32589943

PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.

Yotaro Kudo1, Masayuki Sugimoto2, Esperanza Arias3, Hiroaki Kasashima1, Thekla Cordes4, Juan F Linares5, Angeles Duran5, Yuki Nakanishi1, Naoko Nakanishi1, Antoine L'Hermitte1, Alex Campos1, Nadia Senni1, Tarmo Rooslid1, Lewis R Roberts6, Ana Maria Cuervo3, Christian M Metallo4, Michael Karin7, Maria T Diaz-Meco5, Jorge Moscat8.   

Abstract

Oxidative stress plays a critical role in liver tissue damage and in hepatocellular carcinoma (HCC) initiation and progression. However, the mechanisms that regulate autophagy and metabolic reprogramming during reactive oxygen species (ROS) generation, and how ROS promote tumorigenesis, still need to be fully understood. We show that protein kinase C (PKC) λ/ι loss in hepatocytes promotes autophagy and oxidative phosphorylation. This results in ROS generation, which through NRF2 drives HCC through cell-autonomous and non-autonomous mechanisms. Although PKCλ/ι promotes tumorigenesis in oncogene-driven cancer models, emerging evidence demonstrate that it is a tumor suppressor in more complex carcinogenic processes. Consistently, PKCλ/ι levels negatively correlate with HCC histological tumor grade, establishing this kinase as a tumor suppressor in liver cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NRF2; PKCζ; PKCι; PKCλ; atypical PKC; autophagy; hepatocellular carcinoma; metabolic reprogramming; oxidative phosphorylation; reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 32589943      PMCID: PMC7423690          DOI: 10.1016/j.ccell.2020.05.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  40 in total

1.  Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression.

Authors:  Michael McMahon; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

Review 2.  Cell signaling and function organized by PB1 domain interactions.

Authors:  Jorge Moscat; Maria T Diaz-Meco; Armando Albert; Sonsoles Campuzano
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

3.  Autophagy-deficient mice develop multiple liver tumors.

Authors:  Akito Takamura; Masaaki Komatsu; Taichi Hara; Ayako Sakamoto; Chieko Kishi; Satoshi Waguri; Yoshinobu Eishi; Okio Hino; Keiji Tanaka; Noboru Mizushima
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

Review 4.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

5.  Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.

Authors:  Li Ma; Yongzhen Tao; Angeles Duran; Victoria Llado; Anita Galvez; Jennifer F Barger; Elias A Castilla; Jing Chen; Tomoko Yajima; Aleksey Porollo; Mario Medvedovic; Laurence M Brill; David R Plas; Stefan J Riedl; Michael Leitges; Maria T Diaz-Meco; Adam D Richardson; Jorge Moscat
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

6.  Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C.

Authors:  Joshua P Gray; Katherine A Burns; Tara L Leas; Gary H Perdew; John P Vanden Heuvel
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

Review 7.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

Review 8.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

9.  Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.

Authors:  Maria T Diaz-Meco; Jorge Moscat; Tania Valencia; Ji Young Kim; Shadi Abu-Baker; Jorge Moscat-Pardos; Christopher S Ahn; Miguel Reina-Campos; Angeles Duran; Elias A Castilla; Christian M Metallo
Journal:  Cancer Cell       Date:  2014-07-04       Impact factor: 31.743

Review 10.  How mitochondria produce reactive oxygen species.

Authors:  Michael P Murphy
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

View more
  30 in total

1.  Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.

Authors:  Raquel Gómez-Sintes; Esperanza Arias
Journal:  Mol Aspects Med       Date:  2021-10-07

Review 2.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

3.  cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus.

Authors:  Jiayin Zheng; Yue Wang; Yue Liu; Song Han; Ying Zhang; Yanlin Luo; Yi Yan; Junfa Li; Li Zhao
Journal:  Neurosci Bull       Date:  2022-05-21       Impact factor: 5.271

Review 4.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

5.  PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.

Authors:  Juan F Linares; Xiao Zhang; Anxo Martinez-Ordoñez; Angeles Duran; Hiroto Kinoshita; Hiroaki Kasashima; Naoko Nakanishi; Yuki Nakanishi; Ryan Carelli; Luca Cappelli; Esperanza Arias; Masakazu Yashiro; Masaichi Ohira; Sanjay Patel; Giorgio Inghirami; Massimo Loda; Ana Maria Cuervo; Maria T Diaz-Meco; Jorge Moscat
Journal:  Mol Cell       Date:  2021-09-23       Impact factor: 17.970

Review 6.  The role of redox system in metastasis formation.

Authors:  Chiara Cencioni; Valentina Comunanza; Emanuele Middonti; Edoardo Vallariello; Federico Bussolino
Journal:  Angiogenesis       Date:  2021-04-28       Impact factor: 10.658

Review 7.  Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma.

Authors:  Marina Serra; Amedeo Columbano; Andrea Perra; Marta Anna Kowalik
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

8.  An Orthotopic Implantation Mouse Model of Hepatocellular Carcinoma with Underlying Liver Steatosis.

Authors:  Hiroaki Kasashima; Angeles Duran; Tania Cid-Diaz; Yotaro Kudo; Maria T Diaz-Meco; Jorge Moscat
Journal:  STAR Protoc       Date:  2020-11-20

9.  MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma.

Authors:  Yuling Liu; Yuanzhou Zhang; Bowen Xiao; Ning Tang; Jingying Hu; Shunshun Liang; Yechun Pang; Huili Xu; Junping Ao; Juan Yang; Xiaofei Liang; Lin Wei; Yunfeng Wang; Xiaoying Luo
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

10.  SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.

Authors:  Jie Li; Ming-Han Li; Tian-Tian Wang; Xiao-Ning Liu; Xiao-Ting Zhu; Yun-Zhang Dai; Ke-Chao Zhai; Yong-da Liu; Jia-Li Lin; Rui-Liang Ge; Shu-Han Sun; Fang Wang; Ji-Hang Yuan
Journal:  Br J Cancer       Date:  2021-07-17       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.